Analytical Data
-
Gene name
DDT
- Application
-
Alternative Names
D-DT; D-dopachrome decarboxylase; D-dopachrome tautomerase; Phenylpyruvate tautomerase II; EC 4.1.1.84; MIF2; DDCT
-
Species
Cynomolgus
-
Source
E. coli
-
Tag
N-8*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
XP_005595435
-
Expression Region
P2-L118
-
Protein Length
Full Length of Mature Protein
-
Molecular Weight
13.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DDT (Dengue Virus Non-Structural Protein 1 Domain-Derived Recombinant Protein) research has gained significant attention due to the increasing prevalence of dengue fever, a mosquito-borne viral infection that poses a major public health challenge in tropical and subtropical regions. DDT is derived from the non-structural protein 1 (NS1) of the dengue virus, which plays a crucial role in viral replication and immune response modulation. Studies have shown that NS1 is not only critical for the virus's life cycle but also serves as a biomarker for dengue diagnosis and severity assessment. The focus on recombinant DDT proteins stems from their potential as a platform for vaccine development, diagnostic tools, and therapeutic interventions. By utilizing genetic engineering techniques, researchers can produce DDT in a controlled environment, enhancing its availability and safety for use in various applications. Furthermore, understanding the molecular mechanisms of DDT interaction with the host immune system can inform strategies to mitigate dengue virus infection and improve clinical outcomes. As the global incidence of dengue continues to rise, the development of efficient DDT-based solutions is essential for addressing the growing burden of this disease.
